Kisspeptin与ICSI后胚胎着床
在澳大利亚概念不育医学中心进行横断面研究,纳入176例20至42岁经ICSI助孕女性,于HCG日检测血清kisspeptin水平。临床妊娠组kisspeptin显著高于未妊娠组(P<0.001),与妊娠正相关(r=0.388;P<0.001),AUC为0.784(95%CI 0.681至0.886),提示HCG日kisspeptin可作为ICSI治疗成功的标志物。
要点
- 临床妊娠组HCG日血清kisspeptin水平显著高于未妊娠组(P<0.001)。
- Kisspeptin与临床妊娠正相关(r=0.388;P<0.001),与内膜厚度仅边缘相关(r=0.294;P=0.05)。
- Kisspeptin预测临床妊娠的AUC为0.784(95%CI 0.681至0.886)。
核心结论
- HCG日测定的kisspeptin可作为ICSI后女性治疗成功的标志物。
研究设计与样本
- 横断面研究,2014年6月至2015年6月在澳大利亚概念不育医学中心开展。
- 纳入176例20至42岁、月经规律、甲状腺功能及泌乳素水平正常并选择ICSI的女性。
- 排除子宫肌瘤、代谢性疾病及短效激动剂和拮抗剂方案者,采用长方案降调节。
主要发现
- 按β-HCG分为A组未妊娠(β-HCG<25 mIU/ml)与B组临床妊娠(β-HCG>25 mIU/ml且经阴道超声见心管搏动)。
- B组kisspeptin水平显著高于A组(P<0.001)。
- Kisspeptin与阳性妊娠独立相关(r=0.388;P<0.001),与子宫内膜厚度仅边缘相关(r=0.294;P=0.05)。
- Kisspeptin预测阳性妊娠的曲线下面积最高,为0.784(95%CI 0.681至0.886)。
关键数值与推荐
- 未妊娠组定义为β-HCG<25 mIU/ml。
- 临床妊娠组定义为β-HCG>25 mIU/ml且经阴道超声见心管搏动。
临床怎么用
- 原文结论认为HCG日测定的kisspeptin可作为ICSI后女性治疗成功的标志物。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A cross-sectional study was carried out at the Australian Concept Infertility Medical Centre from June 2014 to June 2015 to relate serum kisspeptin levels on human chorionic gonadotrophin (HCG) day with pregnancy outcome after intracytoplasmic sperm injection (ICSI). A total of 176 women aged 20 to 42 years, with regular menstrual cycles, normal thyroid function and prolactin levels selected for ICSI were included in the study. Patients with uterine fibroids, metabolic disorders, short agonist and antagonist protocol were excluded. Long protocol for down-regulation of ovaries was observed and kisspeptin levels were estimated on HCG day. Results were categorized into groups: Group A, non-pregnant with β-HCG <25 mIU/ml; and Group B, clinical pregnancy with β-HCG >25 mIU/ml and cardiac activity on transvaginal scan. Kisspeptin levels were significantly higher in Group B versus Group A (P < 0.001), independently associated with positive pregnancy (r = 0.388; P < 0.001), but just borderline with endometrial thickness (r = 0.294; P = 0.05). The area under the curve was highest for kisspeptin, 0.784 (95% CI, 0.681 to 0.886) for positive pregnancy, which indicated that kisspeptin measured on HCG day can be used as a marker for success of treatment in women after ICSI.
引用
- Jamil Z, Fatima SS, Arif S, et al. Kisspeptin and embryo implantation after ICSI. Reprod Biomed Online. 2016. PMID: 27908602. doi:10.1016/j.rbmo.2016.11.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。